Form 8-K · Current report

Procter & Gamble 8-K, filed Oct 30, 2026

Filed
CIK
0000080424
Accession no.
0001628280-26-068591
AI-generated summary

Summary

The Procter & Gamble Company closed an underwritten public offering of $4 billion in notes across four tranches — $750 million of 5.125% notes due 2031, $750 million of 5.300% notes due 2033, $1.25 billion of 5.450% notes due 2036 and $1.25 billion of 5.900% notes due 2056 — under its Form S-3 registration statement.

Key points

  • The offering comprised four tranches totaling $4 billion in aggregate principal amount.
  • The notes carry coupons of 5.125%, 5.300%, 5.450% and 5.900%, maturing in 2031, 2033, 2036 and 2056 respectively.
  • The notes were issued under P&G's Registration Statement on Form S-3 (Registration No. 333-299472).
  • Legal opinions on the notes were filed from P&G Assistant General Counsel Travonte Warren and from Fried, Frank, Harris, Shriver & Jacobson LLP.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 8.01Other Events
  • 9.01Financial Statements and Exhibits

From the filing

Item 8.01 Other Events. On October 30, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of $750,000,000 aggregate principal amount of 5.125% Notes due October 30, 2031, $750,000,000 aggregate principal amount of 5.300% Notes due October 30, 2033, $1,250,000,000 aggregate principal amount of 5.450% Notes due October 30, 2036 and $1,250,000,000 aggregate principal amount of 5.900% Notes due October 30, 2056 under the Company’s Registration Statement on Form S-3 (Registration No. 333-299472). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Procter & Gamble in Readster

Add Procter & Gamble to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.